logo
Celcius unveils Rs 50-cr cold supply chain arm for pharma

Celcius unveils Rs 50-cr cold supply chain arm for pharma

Hans India3 days ago
Hyderabad: Celcius Logistics, one of India's leading tech-driven third-party logistics (3PL) and cold supply chain providers, has announced the launch of Celcius+, a specialised vertical dedicated to pharmaceutical logistics. The new division aims to deliver GDP-compliant, tech-enabled solutions for the safe and efficient transportation of vaccines, biologics, insulin, and other temperature-sensitive medicines.
The company will invest Rs50 crore in the initial phase, with the goal of achieving Rs100 crore in annual recurring revenue (ARR) from this segment within the next 18 months. Of the investment, Rs35 crore will be used to deploy 100 new reefer vehicles along key pharma corridors, while Rs10–15 crore will fund a pharma courier system to cater to high-demand urban and semi-urban markets.
To support the expansion, Celcius plans to hire 30–40 specialists in pharma logistics, operations, and compliance. Leveraging its proprietary technology platform, Celcius+ will offer real-time tracking, continuous temperature monitoring, and AI-enabled route optimisation. The fleet will feature 24-ft reefer vehicles equipped with digital locks, CCTV surveillance, and 24/7 monitoring through a central control tower, ensuring product integrity and operational transparency.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

I-T dept finds under-reporting of real estate transactions in Nagpur
I-T dept finds under-reporting of real estate transactions in Nagpur

Time of India

time2 days ago

  • Time of India

I-T dept finds under-reporting of real estate transactions in Nagpur

Nagpur: The income tax department has found gross under-reporting of real estate transactions in yet another sub-registrar office (SRO), this time in Nagpur. An earlier scrutiny had revealed that property registrations worth close to Rs1,000 crore were not reported to the department by the SRO Hingna. Gross under-reporting has now been detected in SRO-7, which covers areas under Nagpur city. Primary investigations showed that deals worth close to Rs500 crore were not reported by the SRO. The investigations are continuing. The action was taken by the income tax's Intelligence and Criminal Investigation (I&CI) wing, which also oversees reporting under the Statement of Financial Transaction (SFT) by various agencies. An initial probe into the returns based on the findings showed a number of individuals who reported income running up to Rs10 to 20 lakh a year, purchased properties running into tens of crores. The money for the purchases was shown as unsecured loans, said sources. In a number of cases, capital gains were not paid by the sellers of properties. Any registration of a property worth over Rs30 lakh has to be reported under SFT. This helps the taxman keep tabs on deals that may not have been reported in the tax returns. Sources say some of the deals not reported by the SRO include those by some prominent persons in the city. A similar under-reporting was unearthed in Malkapur tehsil of Buldhana too. Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and silver prices in your area.

Celcius unveils Rs 50-cr cold supply chain arm for pharma
Celcius unveils Rs 50-cr cold supply chain arm for pharma

Hans India

time3 days ago

  • Hans India

Celcius unveils Rs 50-cr cold supply chain arm for pharma

Hyderabad: Celcius Logistics, one of India's leading tech-driven third-party logistics (3PL) and cold supply chain providers, has announced the launch of Celcius+, a specialised vertical dedicated to pharmaceutical logistics. The new division aims to deliver GDP-compliant, tech-enabled solutions for the safe and efficient transportation of vaccines, biologics, insulin, and other temperature-sensitive medicines. The company will invest Rs50 crore in the initial phase, with the goal of achieving Rs100 crore in annual recurring revenue (ARR) from this segment within the next 18 months. Of the investment, Rs35 crore will be used to deploy 100 new reefer vehicles along key pharma corridors, while Rs10–15 crore will fund a pharma courier system to cater to high-demand urban and semi-urban markets. To support the expansion, Celcius plans to hire 30–40 specialists in pharma logistics, operations, and compliance. Leveraging its proprietary technology platform, Celcius+ will offer real-time tracking, continuous temperature monitoring, and AI-enabled route optimisation. The fleet will feature 24-ft reefer vehicles equipped with digital locks, CCTV surveillance, and 24/7 monitoring through a central control tower, ensuring product integrity and operational transparency.

Cement companies end June quarter with solid growth on volume rebound and higher realisations
Cement companies end June quarter with solid growth on volume rebound and higher realisations

Mint

time3 days ago

  • Mint

Cement companies end June quarter with solid growth on volume rebound and higher realisations

Cement companies wrapped up the June quarter with a solid performance, driven by higher realizations following price hikes and robust volume growth, with most companies reporting double-digit volume growth aided by a low base during last year's election period, an upswing in commercial activity, and a ramp-up in government project execution. A drop in operating costs also contributed to a sharp rise in EBITDA per tonne. The volume growth was led by Ambuja (16.5%), UltraTech Cement (15.3%), JK Cement (14.3%), and Sagar Cements (11.5%), supported by a rebound in demand. Shree Cement's volumes, however, declined by 7.2% due to geopolitical tensions in the northern region. Dalmia Bharat (-5.4%) was impacted by the discontinuation of tolling volumes from Jaypee, while Ramco Cements (-6.8%) faced challenges from the early onset of monsoon, according to domestic brokerage firm Systematix Institutional Equities. The brokerage noted that companies under its coverage posted a 6% YoY and 5% sequential rise in realizations, largely driven by price hikes in southern markets. This also led to a sharp increase in EBITDA per tonne, up 35% YoY and 17.8% sequentially. In addition to firm realizations, a decline in power and fuel costs, along with other operating expenses, aided the EBITDA recovery. Energy costs dropped on a YoY basis, helped by nearly a 20% fall in coal prices and softer Brent crude prices. Freight costs for the brokerage coverage universe rose marginally by 2.6% as logistics efficiencies were partly offset by expansion into newer geographies. On the bottom line, the net profit of Ramco Cement soars 142.3% YoY, while Shree Cement, JK Cement, and Dalmia Bharat have surged 94.8% YoY, 65.6% YoY, and 46.9% YoY, respectively. Cement prices remained flat month-on-month in August 2025 but were relatively stronger year-on-year. The brokerage noted that monsoon slowed construction activity, especially in rural and infrastructure projects, resulting in weaker offtake and limiting companies' ability to raise or sustain prices. The demand in the East fell sharply due to early rains, though prices held steady at Rs353 per bag. In the South, prices rose by Rs10 per bag despite the monsoon, though a correction of Rs5–10 per bag is anticipated in the next quarter. As per the brokerage, central prices dipped by Rs5 per bag, while the North remained unchanged at Rs365 per bag. On an all-India basis, prices had risen 1.2% MoM in August 2025 to Rs360/bag. Channel checks indicate that while demand weakened due to the monsoon, conditions are better than the same period last year. Despite the near-term seasonal slowdown, brokerage remained positive on the sector, expecting a recovery in the second half of the year led by robust demand in infrastructure and urban housing, benign input prices, and increasing thrust on green power. As most of the consolidation is over, it foresees a strong revival in prices and a 7-8% volume growth for H2FY26. Ultratech and Ambuja remain the brokerage's top picks within the coverage universe, with a price target of ₹ 14,481 and ₹ 722, respectively. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store